945TiP JADE: A phase (ph) III study to evaluate dostarlimab vs placebo (PBO) as sequential therapy after chemoradiation (CRT) in patients (pts) with locally advanced unresected head and neck squamous cell carcinoma (LA-HNSCC)
| Autor: | Machiels, J-P., Burtness, B., Harrington, K.J., Saba, N.F., Tahara, M., Crossman, T., Hua, L., Perera, A.D., Theti, D.S., Zografos, E., Siu, L.L. |
|---|---|
| Zdroj: | In Annals of Oncology September 2024 35 Supplement 2:S655-S655 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|